Abigail M.
About Abigail M.
Abigail M. is a Principal Scientist at Bristol Myers Squibb with over 12 years of research experience in molecular and translational neuroscience.
Current Role at Bristol Myers Squibb
Abigail M. is currently a Principal Scientist at Bristol Myers Squibb. In this role, she leverages over 12 years of research experience in molecular and translational Neuroscience to advance the company’s R&D initiatives. Her work includes developing innovative therapies aimed at treating debilitating neurological disorders. Abigail's proven track record in CNS small molecule drug discovery and her expertise in human iPSC technology play a crucial role in her contributions to the team.
Previous Experience at Bristol Myers Squibb
Before becoming a Principal Scientist, Abigail M. held several roles at Bristol Myers Squibb, including Senior Scientist from 2021 to 2022 and Scientist II for two months in 2020. During her tenure, she supported various drug discovery projects, focusing on early target identification, hit identification/expansion, and lead identification phases. Her contributions were integral to advancing multiple CNS small molecule drug discovery projects.
Research History at Biogen
From 2018 to 2020, Abigail M. worked as a Research Scientist at Biogen in Cambridge, MA. In this role, she applied her expertise in human induced pluripotent stem cell (iPSC) technology to develop preclinical in-vitro disease models using iPSC-derived neurons. Her work significantly contributed to the study and discovery of new treatments for CNS disorders, drawing from her deep understanding of molecular and translational Neuroscience.
Postdoctoral Fellowship at AstraZeneca
Abigail M. served as a Postdoctoral Fellow at AstraZeneca from 2015 to 2017 in Maryland. Here, she honed her skills in target validation, assay development, high-throughput screening, and hit-to-lead identification. Her work was pivotal in SAR-enabling studies and the development of methodologies to support mechanism of action (MOA) studies. This fellowship allowed her to cultivate leadership skills in dynamic team environments, further enriching her expertise in CNS drug discovery.
Educational Background
Abigail M. holds a Doctor of Philosophy (PhD) in Neuroscience from the NYU Grossman School of Medicine, where she developed a strong foundation in molecular and translational research. She also earned a Bachelor of Science (BS) from Providence College. Her academic background laid the groundwork for her extensive career in CNS disease modeling and drug discovery, particularly utilizing human iPSC technology.